Blog

Image credit: RheoCube

Amsterdam-based digital lab for R&D simulation platform, RheoCube, has raised over $2M (approx €1.6M) in a fresh round of funding. The round was co-led by investors including Holland Capital and Join Capital.

Solving the pain point?

According to the company, “Digitalisation is a hot topic in R&D departments across the globe.” Current R&D processes are time-consuming mostly because of trial-and-error in physical labs.

The cost of building software

Marek Gajda, CTO of The Software House, shares his insights on building high-quality…Show More

Marek Gajda, CTO of The Software House, shares his insights on building high-quality software. Show Less

If the logging systems were digitised, everything including old insights, comparing new adjustments, understanding the route taken by the R&D team to formulate new tests and outcomes, would have saved time, effort, and money. “Reducing that costly process empowers organisations to build smarter and faster R&D cycles while speeding up time to market.”

“RheoCube is the only digital solution to offer a multi-scale approach to simulations and predictions for complex fluids by simulating lab experiments on supercomputers,” claims the company in a statement.

Here’s how RheoCube is helping

RheoCube is a cloud-based complex fluids simulation platform, that offers a user-friendly alternative to the physical lab approach of trial-and-error. The company also offers integrated cloud computing so that one does not invest in heavy computer clusters. It is often used for prototyping new products and for applied material research.

According to  RheoCube, it develops novel and accurate simulation models. It mentions in a statement, “We run virtual experiments in the form of high-performance computer simulations with the goal to understand, predict, and help improve the rheology and transport of complex fluids and their processing – from blood cells in microfluidic devices to ceramic components in a mixer.”

This simulation platform was created by VC-backed Electric Ant Lab (EAL) and its founder Dr Eric Lorenz (a renowned expert in the field of computational physics). RheoCube’s clients are primarily chemistry-focused R&D scientists in large corporations in sectors such as food, coatings, homecare, personal care, and speciality chemicals. Companies such as Givaudan, Henkel, and Colgate-Palmolive are already using RheoCube to digitise their R&D processes.

Electric Ant Lab (EAL) is a simulation software company based at the Science Park in Amsterdam.

Use of the funds

With this investment, both investors will help to drive the development and commercialisation of RheoCube.

Jurjen van Rees CCO/COO of RheoCube, says “This joint investment by two renowned investors reflects strong confidence in RheoCube as a unique, breakthrough product. It supports us in our mission to drive a major transformation in R&D: digitalisation. RheoCube is changing the game for researchers and is set to become the standard Simulation-as-a-Service solution for R&D labs”.